No Data
No Data
Chimin Health Management (603222.SH): Tariffs on safe syringes and other products exported to the United States have not yet been implemented at the rate of 50%.
Chimin Health Management (603222.SH) stated on the interactive platform on July 3rd that at present, the tariffs on safety syringes and other products exported to the USA have not been implemented at 50%.
Chimin Health Management (603222.SH) has cumulatively spent 86,560,500 yuan to repurchase 2.095% of its shares.
Chimin Health Management (603222.SH) announced on June 28 that as of June 28, 2024, the company had repurchased 11,254,700 shares through centralized bidding trading, accounting for 2.095% of the total share capital of the company. The highest purchase price was 9.98 yuan/share, the lowest was 5.00 yuan/share, and the total amount paid was 86,560,538.18 yuan (excluding transaction fees).
Chimin Health Management (603222.SH): Cumulative expenditure of 83.785 million yuan repurchasing 2.002% of its shares.
On June 6, Gelonhui reported that up to June 6, 2024, Chimin Health Management (603222.SH) had repurchased 10,754,700 shares of the company's stock through centralized bidding trading, accounting for 2.002% of the company's total share capital of 537,237,415 shares. The highest purchase price was 9.98 yuan/share, and the lowest price was 5.00 yuan/share. The total amount paid for the repurchase was RMB 83,785,038 (excluding transaction costs).
Chimin Health Management (603222.SH) has spent 81.7246 million yuan to buy back 1.93% of its shares.
Chimin Health Management (603222.SH) announced that as of May 31, 2024, the company has successfully completed centralized bidding...
Chimin Health Management (603222.SH): No repurchase was implemented by the company in May.
Chimin Health Management (603222.SH) announced on June 4th that the company did not implement repurchase in May 2024. As of May 31, 2024, the company had repurchased a total of 10,389,700 shares through centralized bidding trading, accounting for 1.934% of the company's total share capital. The highest purchase price was 9.98 yuan/share, the lowest was 5.00 yuan/share, and the total amount paid was 81,724,613.18 yuan (excluding transaction costs).
Chimin Health Management Co., Ltd. (SHSE:603222) Stock Rockets 31% As Investors Are Less Pessimistic Than Expected
Chimin Health Management Co., Ltd. (SHSE:603222) shares have continued their recent momentum with a 31% gain in the last month alone. Not all shareholders will be feeling jubilant, since the share
No Data